Alligator orphan drug designation

Alligator Bioscience awarded Orphan Drug Designation for mitazalimab

Lund-based Alligator Bioscience continues to increase the value of its lead asset mitazalimab. The company recently announced receiving Orphan Drug Designation for the CD40...
Strengthened team and cash position for Dicot

Dicot heading towards summer with strengthened team and finances

In August, Dicot is expected to take its biggest step as a development company with the planned initiation of a phase I clinical trial...
Board

Flerie Invest’s Carl-Johan Spak elected to Lipum’s Board

At Lipum's Annual General Meeting on May 10, Carl-Johan Spak was elected as a new board member of Lipum. Carl-Johan is a senior advisor...
Respiratorius continues the hunt for a partner

Respiratorius continues its search for a partner

After good results in the PK study with VAL001, only one activity remains for Respiratorius, to sign an agreement. In a quarter with a...
Neola has started marketing activities

Neola Medical kicks off the market preparations

Neola Medical is in full swing setting the stage for its medical device. While generating interest among neonatal intensive care units around Europe, technical...
Stark tillväxt för Invent Medic

Tripled sales for Invent Medic

It hardly came as a surprise that Invent Medic showed good growth in the first quarter of 2023. A whooping 300 per cent increase...
Stockholm

Highlights from SynAct Pharma’s Capital Markets Day

On May 5, SynAct Pharma held a Capital Markets Day in Stockholm featuring presentations from the management team, as well as Key Opinion Leaders...
Arcede heading towards dosing in tox study

Arcede approaching dosing in tox study

When reporting on first quarter of 2023, Arcede Pharma have an eventful period to look back on. Now all eyes are on the final...

Aqilion – Disrupting the Vicious Cycle of Chronic Inflammation

Chronic inflammation is an underlying cause of many diseases and represents an immense societal burden. Researchers continue to struggle to solve the riddle behind...
Zyneyro's CEO on the collaboration with CombiGene

Zyneyro’s CEO on the collaboration with CombiGene

At the beginning of the year, CombiGene and Zyneyro entered into a collaboration for the development of new treatments for severe chronic pain conditions....